Phase II trial of aclarubicin in advanced breast cancer: A cancer and leukemia group B study

Arlene A. Forastiere, D. R. Budman, F. Richards

Research output: Contribution to journalArticle

Original languageEnglish (US)
JournalCancer Treatment Reports
Volume1137-1138 )
StatePublished - 1983
Externally publishedYes

Fingerprint

Aclarubicin
Leukemia
Breast Neoplasms
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Phase II trial of aclarubicin in advanced breast cancer : A cancer and leukemia group B study. / Forastiere, Arlene A.; Budman, D. R.; Richards, F.

In: Cancer Treatment Reports, Vol. 1137-1138 ), 1983.

Research output: Contribution to journalArticle

@article{177fd5116b394be8986114c7679522aa,
title = "Phase II trial of aclarubicin in advanced breast cancer: A cancer and leukemia group B study",
author = "Forastiere, {Arlene A.} and Budman, {D. R.} and F. Richards",
year = "1983",
language = "English (US)",
volume = "1137-1138 )",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Phase II trial of aclarubicin in advanced breast cancer

T2 - A cancer and leukemia group B study

AU - Forastiere, Arlene A.

AU - Budman, D. R.

AU - Richards, F.

PY - 1983

Y1 - 1983

UR - http://www.scopus.com/inward/record.url?scp=18744420571&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744420571&partnerID=8YFLogxK

M3 - Article

C2 - 6580949

AN - SCOPUS:18744420571

VL - 1137-1138 )

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

ER -